FreshRecalls

⚠ Data freshness notice: the most recent refresh of NHTSA was incomplete, so a very recent recall may be missing. Everything shown is accurate as of the last checked time on this page — for anything time-critical, confirm with the official sources linked below.

FDAClass II · Drug · Recalled June 10, 2026

HyVee recall — Guardian Drug Co. Inc.

Hazard: Presence of foreign substance: small metallic particles in chewable tablets.

Class II: may cause temporary or medically reversible health consequences.

View the official FDA enforcement record (openFDA) ↗

Official recall ID
D-0572-2026
Brand
Guardian Drug Co
Classification
Class II
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS, DISTRIBUTED BY: HY-VEE INC., Inc., WEST DES MOINES, IA 50266, UPC: 0 75450 82514 5.

Affected products

Companies & origin

Recalling firm location
Dayton, NJ, United States
Firm address
2 Charles Ct, 08810-1508

Identifying details (verbatim from the notice)

Product codes / lots
Lot #: 1716089, expires: JAN 2029.
Distribution
U.S.A. Nationwide
Firm notified the public via
Letter
FDA event ID
99098
Recall initiated
May 28, 2026
FDA classified
June 3, 2026
FDA report date
June 10, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 23, 2026 at 11:04 PM UTC.

Report a data error on this page